Home
Contact Us
facebook
twitter
linkedin
menu
Menu
About Us
Show sub menu
arrow-down
Mission
Members
Board of Directors
Staff
Work at ACLA
Economic Impact
Issues
Show sub menu
arrow-down
PAMA Reform
Infrastructure and Innovation
Regulatory Issues
Reimbursement & Coverage
Value of Clinical Labs: The Power of Knowing
Take Action
Newsroom
Show sub menu
arrow-down
ACLA Blog
ACLA Press Releases
Comments and Letters
Spotlight on Lab Professionals
All News
COVID-19
Member Resources
Show sub menu
arrow-down
ACLA 2026 Priorities
CPT Committee
Close Menu
cross
Home
Contact Us
About Us
Show sub menu
arrow-down
Mission
Members
Board of Directors
Staff
Work at ACLA
Economic Impact
Issues
Show sub menu
arrow-down
PAMA Reform
Infrastructure and Innovation
Regulatory Issues
Reimbursement & Coverage
Value of Clinical Labs: The Power of Knowing
Take Action
Newsroom
Show sub menu
arrow-down
ACLA Blog
ACLA Press Releases
Comments and Letters
Spotlight on Lab Professionals
All News
COVID-19
Member Resources
Show sub menu
arrow-down
ACLA 2026 Priorities
CPT Committee
Home
|
All News
|
Comments and Letters
|
ACLA Challenge to FDA’s Final Rule Regulating Laboratory Developed Testing Services as Medical Devices
ACLA Challenge to FDA’s Final Rule Regulating Laboratory Developed Testing Services as Medical Devices
May 29, 2024
Categories:
Comments and Letters
,
Regulatory Issues
Download (PDF, 7.43MB)
Print page / Save as PDF
